Literature DB >> 23954459

Spinal neurofibromatosis in a family with classical neurofibromatosis type 1 and a novel NF1 gene mutation.

Francesco Nicita1, Isabella Torrente2, Alberto Spalice3, Irene Bottillo4, Laura Papetti1, Valentina Pinna1, Fabiana Ursitti1, Martino Ruggieri5.   

Abstract

Familial spinal neurofibromatosis (FSNF) is a rare form of neurofibromatosis type 1 (NF1) characterized by multiple, histologically proven neurofibromas of the spinal roots leaving no intact segments and associated neurofibromas of major peripheral nerves. It is sometimes associated with other NF1 stigmata. Most patients have NF1 gene mutations. We describe a patient who fulfilled the diagnostic criteria for spinal neurofibromatosis and belonged to a family in which other affected members exhibited classical NF1 stigmata. A novel missense (c.7109 T>A; p.Val2370Asp) mutation in exon 39 of the NF1 gene was present in the affected family members. The family displayed extreme phenotypic variability in the spectrum of NF1. To our knowledge, this is the first patient with spinal neurofibromatosis in the context of classical NF1 with an NF1 gene mutation. The term FSNF is inaccurate as this condition simply reflects the typical autosomal dominant pattern of NF1 inheritance with phenotypoc variability and does not encompass patients with sporadic disease or those in the context of a classical NF1 phenotype as reported in the present family. The term could be replaced by "spinal neurofibromatosis".
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Familial spinal neurofibromatosis; NF1; Neurocutaneous syndrome; Neurofibromatosis; Phakomatosis; Spinal cord

Mesh:

Year:  2013        PMID: 23954459     DOI: 10.1016/j.jocn.2013.01.026

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  1 in total

1.  Spinal neurofibromatosis with NF1 mutation in a classic neurofibromatosis type 1 family: A case report and literature review.

Authors:  Zeqian Ning; Zhiqian Yang; Gaofei Chen; Wenjiao Wu; Longshuang He; Yesheng Sun; Dongpeng Cai; Wei Zhang
Journal:  Mol Genet Genomic Med       Date:  2019-11-11       Impact factor: 2.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.